Both in Pharmaceuticals
Supernus vs ANI Pharmaceuticals
Over the past year SUPN returned −50.5% and ANIP returned −24.2%; their daily moves had a correlation of 0.22.
SUPN −50.5% ANIP −24.2%Growth of $1, one year, split-adjusted
| Metric | SUPN | ANIP |
|---|---|---|
| Price | $28.21 | $71.65 |
| Market cap | $1.64B | $1.65B |
| Today | +0.21% | −0.87% |
| 1 month | −34.1% | +0.2% |
| 6 months | −45.2% | −14.8% |
| Year to date | −43.2% | −9.2% |
| 1 year | — | −23.8% |
| Revenue growth (YoY) | +18.0% | +25.9% |
| Gross margin | 88.1% | 62.4% |
| Net margin | 9.2% | 8.6% |
| P/E (TTM) | — | 16.5× |
| Price / sales | 1.9× | 1.7× |
| Net cash | $359.5M | -$234.7M |
| Dividend yield | 28.82% | — |
| Volatility (60d) | 86.1% | 26.7% |
| Short % of float | 7.3% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).